ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
21 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
956
|
295K
|
21
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Rexryan
|
63 |
16K |
1 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
63
|
16K
|
1
|
|
Charts
|
BRN |
Re:
Chart
|
|
Rexryan
|
20K |
8.0M |
4 |
06/02/22 |
06/02/22 |
Charts
|
20K
|
8.0M
|
4
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
5 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
956
|
295K
|
5
|
|
ASX - By Stock
|
SVL |
Re:
"Price Rally For The Ages" Coming w/ Triple Digit Silver | Ed Steer
|
|
Rexryan
|
6 |
4.2K |
1 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
6
|
4.2K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Rexryan
|
10K |
4.7M |
5 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
5
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
1 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
956
|
295K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
0 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
956
|
295K
|
0
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
22 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
956
|
295K
|
22
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
31 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
956
|
295K
|
31
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
4 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
956
|
295K
|
4
|
|
ASX - By Stock
|
BRN |
Re:
Intentionally Misleading Article Pinned to Top of Hotcopper
|
|
Rexryan
|
146 |
43K |
6 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
146
|
43K
|
6
|
|
ASX - By Stock
|
BRN |
Re:
Contrarian views
|
|
Rexryan
|
156 |
75K |
11 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
156
|
75K
|
11
|
|
ASX - By Stock
|
BRN |
Re:
Contrarian views
|
|
Rexryan
|
156 |
75K |
1 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
156
|
75K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
3 |
05/02/22 |
05/02/22 |
ASX - By Stock
|
956
|
295K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
1 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
35 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
35
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
0 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
0
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
0 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
0
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
6 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
6
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
7 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
7
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
3 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
8 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
8
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
5 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
5
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
3 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
3
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
5 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
5
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Rexryan
|
10K |
4.7M |
23 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
23
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
13 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
13
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
2 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
26 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
26
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
14 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
295K
|
14
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
10 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
10
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
2 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Rexryan
|
10K |
4.7M |
4 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
10K
|
4.7M
|
4
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
16 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
16
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
24 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
24
|
|
ASX - By Stock
|
BRN |
Re:
Ann: DTC Eligibility Approved
|
|
Rexryan
|
185 |
90K |
17 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
185
|
90K
|
17
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
2 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
5 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
5
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
7 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
7
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
7 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
7
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
16 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
16
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
4 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
4
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
5 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
5
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
6 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
6
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
4 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
4
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
1 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
18 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
18
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
8 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
8
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
Rexryan
|
956 |
295K |
5 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
295K
|
5
|
|